Efg Asset Management (North America) Corp. Biomarin Pharmaceutical Inc Transaction History
Efg Asset Management (North America) Corp.
- $585 Million
- Q3 2024
A detailed history of Efg Asset Management (North America) Corp. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Efg Asset Management (North America) Corp. holds 41,844 shares of BMRN stock, worth $2.79 Million. This represents 0.5% of its overall portfolio holdings.
Number of Shares
41,844
Previous 77,490
46.0%
Holding current value
$2.79 Million
Previous $6.38 Million
53.9%
% of portfolio
0.5%
Previous 1.13%
Shares
9 transactions
Others Institutions Holding BMRN
# of Institutions
637Shares Held
177MCall Options Held
2.01MPut Options Held
1.28M-
Black Rock Inc. New York, NY22.7MShares$1.52 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.3MShares$1.28 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.9MShares$1.26 Billion0.99% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$926 Million0.59% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.5MShares$699 Million0.16% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $12.4B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...